Valuation Cocrystal Pharma, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-25 EDT			5-day change	1st Jan Change
1.170 ^USD	+1.74%		-3.31%	+19.51%

09-09	Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment	CI
08-17	Cocrystal Pharma, Inc. Announces Appointment of Carol Brosgart, Md to Board of Directors, Effective August 12, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	63.35	15.88	17.52	20.55	13.49	22.54	-	-
Change	-	-74.94%	10.34%	17.29%	-34.34%	67.01%	-	-
Enterprise Value (EV)	63.35	15.88	17.52	20.55	13.49	22.54	22.54	22.54
Change	-	-74.94%	10.34%	17.29%	-34.34%	67.01%	0%	0%
P/E	-4.06x	-0.41x	-0.92x	-1.17x	-1.26x	-1.7x	-2.02x	-1.86x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0x	0x	0.15x	0x	0.1x	0.1x	-0.22x
Capitalization / Revenue	-	-	-	-	-	-	-	-
EV / Revenue	-	-	-	-	-	-	-	-
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-1.96x	-1.91x	-1.59x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.92	-4.77	-1.87	-1.72	-0.78	-0.69	-0.58	-0.63
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-	-	-
EBITDA	-	-	-18.37	-	-	-	-	-
EBIT ¹	-14.22	-38.83	-18.56	-17.88	-9.019	-11.5	-11.8	-14.2
Net income ¹	-14.18	-38.84	-17.98	-17.5	-8.831	-11.3	-11.5	-13.9
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	7.800	1.950	1.722	2.020	0.979	1.170	1.170	1.170
Nbr of stocks (in thousands)	8,122	8,143	10,174	10,174	13,784	19,263	-	-
Announcement Date	3/23/22	3/29/23	3/28/24	3/31/25	3/31/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
COCRYSTAL PHARMA, INC.	-1.7x	-	-	-	22.54M
WUXI APPTEC CO., LTD.	21.09x	7.5x	15.07x	1.41%	72.26B
ARGENX SE	31.3x	9.02x	28.11x	0.04%	60.24B
WUXI BIOLOGICS (CAYMAN) INC.	32.1x	6.85x	17.78x	-.--%	27.73B
INSMED INCORPORATED	-72.3x	13.87x	-75.56x	-.--%	25.73B
BIONTECH SE	-15.17x	5.73x	-7.2x	-.--%	24.75B
GENMAB A/S	28.46x	5.35x	17.81x	-.--%	20.74B
PHARMAESSENTIA CORPORATION	42.74x	15.97x	32.4x	0.35%	15.06B
EXELIXIS, INC.	17.96x	5.35x	12.5x	-.--%	14.41B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1015.79x	35.53x	613.78x	-.--%	14.23B
Average	110.03x	11.69x	72.74x	0.2%	27.52B
Weighted average by Cap.	65.45x	9.84x	39.70x	0.4%